| Number of people receiving naloxone | Number of naloxone doses distributed | Number of OEND best practices implemented | |||
---|---|---|---|---|---|---|
Sessions | IRR (95% CI) | p-value | IRR (95% CI) | p-value | Mean difference (95% CI) | p-value |
Control SSPs | - | Â | - | Â | - | Â |
OMIE SSPs: < 10 sessions | 1.32 (0.76–2.29) | 0.33 | 0.96 (0.51–1.79) | 0.90 | 0.10 (− 1.09, 1.29) | 0.87 |
OMIE SSPs: 10 + sessions | 2.65 (1.66–4.22) |  < 0.001 | 2.94 (1.67–5.20) |  < 0.001 | 0.22 (− 0.75, 1.19) | 0.66 |
Hours | IRR (95% CI) | p-value | IRR (95% CI) | p-value | Mean difference (95% CI) | p-value |
Control SSPs | - | Â | - | Â | - | Â |
OMIE SSPs: < 12 h | 1.52 (0.91–2.55) | 0.11 | 0.99 (0.56–1.75) | 0.90 | 0.02 (− 1.04, 1.08) | 0.97 |
OMIE SSPs: 12 + h | 2.69 (1.65–4.41) |  < 0.001 | 3.02 (1.72–5.29) |  < 0.001 | 0.33 (− 0.72, 1.38) | 0.54 |